123 related articles for article (PubMed ID: 12553000)
41. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
42. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
44. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
Garcia FU; Haber MM; Chen X
Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
[TBL] [Abstract][Full Text] [Related]
45. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
46. Expression of p63 in thymomas and normal thymus.
Dotto J; Pelosi G; Rosai J
Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
[TBL] [Abstract][Full Text] [Related]
47. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
Iwata T; Uramoto H; Sugio K; Fujino Y; Oyama T; Nakata S; Ono K; Morita M; Yasumoto K
Lung Cancer; 2005 Oct; 50(1):67-73. PubMed ID: 15950316
[TBL] [Abstract][Full Text] [Related]
48. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.
Reis-Filho JS; Preto A; Soares P; Ricardo S; Cameselle-Teijeiro J; Sobrinho-Simões M
Mod Pathol; 2003 Jan; 16(1):43-8. PubMed ID: 12527712
[TBL] [Abstract][Full Text] [Related]
49. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
50. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
51. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
52. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M
Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439
[TBL] [Abstract][Full Text] [Related]
53. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
54. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
55. Elevated expression of p63 protein in human esophageal squamous cell carcinomas.
Hu H; Xia SH; Li AD; Xu X; Cai Y; Han YL; Wei F; Chen BS; Huang XP; Han YS; Zhang JW; Zhang X; Wu M; Wang MR
Int J Cancer; 2002 Dec; 102(6):580-3. PubMed ID: 12447998
[TBL] [Abstract][Full Text] [Related]
56. [Efficiency of immunohistochemical study of high-molecular-weight cytokeratins (CKR-HMW) and p63 in prostate trepan biopsy specimens for establishing the diagnosis of adenocarcinoma].
Raskin GA
Arkh Patol; 2009; 71(6):48-9. PubMed ID: 20131510
[TBL] [Abstract][Full Text] [Related]
57. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues.
Bilal H; Handra-Luca A; Bertrand JC; Fouret PJ
J Histochem Cytochem; 2003 Feb; 51(2):133-9. PubMed ID: 12533521
[TBL] [Abstract][Full Text] [Related]
58. Loss of p63 expression is associated with tumor progression in bladder cancer.
Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
[TBL] [Abstract][Full Text] [Related]
59. The relationship between p63 and p53 expression in normal and neoplastic breast tissue.
Ribeiro-Silva A; Zambelli Ramalho LN; Britto Garcia S; Zucoloto S
Arch Pathol Lab Med; 2003 Mar; 127(3):336-40. PubMed ID: 12653579
[TBL] [Abstract][Full Text] [Related]
60. Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.
Song G; Hsiao H; Wang JL; Mannion C; Stojadinovic A; Avital I; Fu SW; Mason J; Chen W; Jewett A; Li H; Man YG
Anticancer Res; 2014 Nov; 34(11):6363-80. PubMed ID: 25368236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
